Home
About
Overview
Sharing Data
ORCID
Help
History (1)
Nivolumab for Patients With High-Risk Oral Leukoplakia: A Nonrandomized Controlled Trial.
See All Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Nivolumab for Patients With High-Risk Oral Leukoplakia: A Nonrandomized Controlled Trial.
Nivolumab for Patients With High-Risk Oral Leukoplakia: A Nonrandomized Controlled Trial. JAMA Oncol. 2024 Jan 01; 10(1):32-41.
View in:
PubMed
subject areas
B7-H1 Antigen
Carcinoma, Squamous Cell
Female
Humans
Immunotherapy
Leukoplakia, Oral
Male
Middle Aged
Mouth Neoplasms
Precancerous Conditions
Programmed Cell Death 1 Receptor
Tumor Microenvironment
authors with profiles
Ezra Cohen